International pharmaceutical manufacturer Roche Pharma, which has bases in East Sussex and Hertfordshire, has been suspended from practice in the UK for a minimum of six months by the Association of the British Pharmaceutical Industry (ABPI).
The ABPI deemed that the firm had taken action ‘likely to bring discredit on, or reduce confidence in, the pharmaceutical industry,’ in contravention of clause two of the ABPI code of practice, when between 2003 and 2005 it supplied the prescription-only obesity drug Xenical to private diet clinics. It was also alleged that the firm…
This content is for subscribers only. Subscribe now for free to read the full article.
Already a subscriber? Login
